FEATURED/ARCHIVES (04/05/24)

×

Bupropion for Major Depressive Disorder or Persistent Depressive Disorder (Dysthymia) · April 2021

Publications (Books-Reports)

Canadian Agency for Drugs and Technologies in Health

×

Pharmacogenomic Testing in Depression: A 2021 Update · January 2022

Publications (Books-Reports)

Canadian Agency for Drugs and Technologies in Health

×

Bupropion for Treatment Resistant Depression · April 2021

Publications (Books-Reports)

Canadian Agency for Drugs and Technologies in Health

×

Ketamine for Adults with Treatment-Resistant Depression or Posttraumatic Stress Disorder: A 2023 Update · January 2024

Publications (Books-Reports)

Canadian Agency for Drugs and Technologies in Health

×

Pharmacogenomic Testing in Depression: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines · February 2020

Publications (Books-Reports)

Canadian Agency for Drugs and Technologies in Health

ARCHIVES UPDATED APR2023 - TOP OF THE PAGE - SEARCH MORE RESOURCES